Results 311 to 320 of about 443,069 (407)
6. Mixed Connective Tissue Diseases
, 2007 Yoshinori Nonomura, Nobuyuki Miyasaka
openalex +2 more sources
A Universal Biomimetic Approach for Making Artificial Antigen‐Presenting Cells for T Cell Activation
Advanced Functional Materials, EarlyView.This study shows a biomimetic silica microcapsule (SMC) fabrication method under mild conditions for making artificial antigen‐presenting cells (aAPCs). Inspired by marine biomineralization, peptide‐mediated biosilicification enables silica shell formation on emulsion templates. The resulting SMCs possess a core–shell structure, controlled fluorescence
Fei Hou +5 more
wiley +1 more source
Microbubble‐Controlled Delivery of Biofilm‐Targeting Nanoparticles to Treat MRSA Infection
Advanced Functional Materials, EarlyView.Here, an effective strategy using microbubble (MB)‐controlled delivery of biofilm‐targeting nanoparticles (BTNs) for removal and therapy of methicillin‐resistant Staphylococcus aureus (MRSA) biofilm infections is introduced. In vivo delivery of MB with BTN is demonstrated to silence key bacterial genes involved in biofilm formation (icaA), bacterial ...
Ju Yeon Chung +6 more
wiley +1 more source
Advanced Healthcare Materials, Volume 14, Issue 9, April 4, 2025.Microneedle‐assisted RA therapy with MC complexes in CCMNP effectively treats cartilage degradation and synovitis without visceral damage. The dual capability in therapeutic intervention and in situ monitoring inflammation through local pH and ROS levels facilitates the dynamic adjustment of treatment protocols and represents a paradigm shift in the RA
Lili Jin +6 more
wiley +1 more source
Epidemiologi ved blandet bindevevsykdom, mixed connective tissue disease (MCTD) hos barn [PDF]
Norsk Epidemiologi, 2008 Odd Vinje, Berit Flatø
doaj
Advanced Healthcare Materials, Volume 14, Issue 7, March 14, 2025.This review highlights emerging bioengineering strategies for treating neointimal hyperplasia in the peripheral vasculature, focusing on approaches that promote re‐endothelialization, modulate smooth muscle cell phenotype, reduce inflammation, mitigate oxidative stress, and optimize biomechanical compliance.
Nikita Wilson John +5 more
wiley +1 more source
Nanozymes for Treating Ocular Diseases
Advanced Healthcare Materials, Volume 14, Issue 8, March 25, 2025.Nanozymes, with their nanoscale size and enzyme‐like activities, can reduce inflammation and oxidative stress associated with various ocular diseases. Recent research explores their integration with soft materials, nanoparticles, and drug delivery systems, promising enhanced therapeutic outcomes.
Ka‐Ying Wong +2 more
wiley +1 more source
Case history of mixed connective tissue disease
, 2011 Artem A. Verkhotin +2 more
openalex +2 more sources
Oxidized Carbon Nanoparticles Enhance Cellular Energetics With Application to Injured Brain
Advanced Healthcare Materials, Volume 14, Issue 8, March 25, 2025.Oxidized carbon nanozymes (OCNs) that catalyze the dismutation of superoxide radical and oxidation of reduced nicotinamide adenine dinucleotide (NADH) to NAD+ promote glycolytic and mitochondrial energy metabolism under impaired conditions observed in traumatic brain injury with hemorrhage.
Karthik Mouli +11 more
wiley +1 more source
Iron‐MOFs for Biomedical Applications
Advanced Healthcare Materials, Volume 14, Issue 8, March 25, 2025.This review introduces the unique properties of iron‐based metal–organic frameworks (Fe‐MOFs), the advances in synthesis and formulation, and their state‐of‐the‐art applications in biomedicine. It discusses the challenges in transitioning Fe‐MOFs from research to clinical use, emphasizing the need for eco‐friendly production methods, and a deeper ...
Zhihao Yu +2 more
wiley +1 more source